SCHEMBL23731339

SCHEMBL23731339

C[C@H]1C[C@@H](NC(=O)c2cnc3cc(OC(F)F)c(Cl)cc3c2)C1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 20/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19021519 0.93 HPGDS (0.52) HPGDS
SCHEMBL19021516 0.91 HPGDS (0.56) HPGDS
SCHEMBL18988533 0.91 HPGDS (0.54) HPGDS
SCHEMBL18988534 0.91 HPGDS (0.54) HPGDS
SCHEMBL18987788 0.88 HPGDS (0.61) HPGDS
SCHEMBL18987790 0.88 HPGDS (0.61) HPGDS
SCHEMBL19021455 0.88 HPGDS (0.54) HPGDS
SCHEMBL18987497 0.88 HPGDS (0.53) HPGDS
SCHEMBL18987499 0.88 HPGDS (0.53) HPGDS
SCHEMBL18987515 0.87 HPGDS (0.48) HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238162-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2021-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238162-A1 CHEMICAL COMPOUNDS HPGDS, PTGS1, PTGIS HPGDS 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback